Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial

Published:2014-09 Issue:3 Volume:134 Page:568-575.e7
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Mosbech Holger,Deckelmann Regina,de Blay Fréderic,Pastorello Elide Anna,Trebas-Pietras Ewa,Andres Luis Prieto,Malcus Inga,Ljørring Christian,Canonica Giorgio Walter

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. Prevalence and rate of diagnosis of allergic rhinitis in Europe;Bauchau;Eur Respir J,2004

2. Global burden of asthma;Masoli;Allergy,2004

3. A population-based clinical study of allergic and non-allergic asthma;Knudsen;J Asthma,2009

4. Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey;Zureik;BMJ,2002

5. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study;Linneberg;Allergy,2002

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world evidence of allergen immunotherapy;Current Opinion in Allergy & Clinical Immunology;2024-08-30

2. Sublingual allergen immunotherapy prevents house dust mite inhalant type 2 immunity through dendritic cell-mediated induction of Foxp3+ regulatory T cells;Mucosal Immunology;2024-08

3. The evidence for commercial house dust mite immunotherapy products: A pragmatic systematic review with narrative synthesis;Journal of Allergy and Clinical Immunology: Global;2024-08

4. Allergen immunotherapy in asthma;Allergology International;2024-07

5. Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study);The Lancet Regional Health - Europe;2024-06